Work with thought leaders and academic experts in Internal Medicine

Companies can greatly benefit from collaborating with academic researchers in the field of Internal Medicine. These experts can provide valuable insights and expertise in various areas such as research, product development, and medical consulting. By working with Internal Medicine thought leaders, companies can enhance their understanding of diseases, develop innovative medical solutions, and improve patient care. Additionally, academic researchers can contribute to clinical trials, conduct data analysis, and provide evidence-based recommendations. Collaborating with Internal Medicine experts can give companies a competitive edge in the healthcare industry and help them stay at the forefront of medical advancements.

Researchers on NotedSource with backgrounds in Internal Medicine include Dr. Everson A Nunes, Ph.D., John M Baust, Ph.D, Jeffrey Townsend, Balamurugan Tangiisuran, Steve Joordens, Mohsen Fathzadeh, Luke Connelly, Monica Motley, PhD, MSEd, MPH, Roshonda Jones, Yuri Bukhtiyarov, Miguel Ramirez, Marina Baretti, and Maria Daniela Defagó.

Dr. Everson A Nunes, Ph.D.

Hamilton, Ontario, Canada
19 Years Experience
Post-Doctoral Fellow at McMaster University | former Associate Professor - Physiological Sciences
Education

Universidade Federal do Paraná - Campus Centro Politécnico

PhD, Physiological Sciences / December, 2009

Curitiba

Universidade Federal do Paraná - Campus Centro Politécnico

BSc - Human Nutrition / December, 2007

Curitiba

Universidade Federal do Paraná - Campus Centro Politécnico

MSc, Physiological Sciences / March, 2005

Curitiba
Experience

McMaster University

Post Doctoral Fellow / September, 2019 — Present

Post-Doctoral Research Fellow / September, 2015 — August, 2016

Universidade Federal de Santa Catarina

Associate professor / October, 2013 — April, 2022

Assistant Professor / October, 2010 — September, 2013

Universidade Federal do Paraná

Post-Doctoral Fellow / December, 2009 — September, 2010

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (39)
skeletal muscle
nutrition
physical activity
obesity
cancer
And 34 more
About
Dr. Everson A Nunes is a highly accomplished researcher and educator in the field of physiological sciences. He received his Ph.D. in Cellular and Molecular Biology with a focus on Physiological Sciences from Universidade Federal do Paraná in 2009, after completing a BSc in Human Nutrition and an MSc in Physiological Sciences. He also holds a specialization in Exercise Physiology and a BSc in Biological Sciences from Universidade Federal do Paraná. Dr. Nunes has a strong background in research, having completed two post-doctoral fellowships at McMaster University and Universidade Federal do Paraná. He has also held positions as an associate professor and assistant professor at Universidade Federal de Santa Catarina. He has published numerous articles in peer-reviewed journals, and his research focuses on the effects of exercise and nutrition on physiological processes in the human body. In addition to his research, Dr. Nunes is also a dedicated educator. He has taught at various universities in Brazil, including Universidade Federal de Santa Catarina, Universidade Gama Filho, Faculdades Integradas Espírita, Pontificia Universidade Católica do Paraná, and Faculdade do Litoral Sul. He is known for his dynamic teaching style and his ability to engage students in complex physiological concepts. Dr. Nunes is a member of several professional organizations, including the American Society for Nutrition, the Canadian Society of Exercise Physiology, the Canadian Nutrition Society and the Brazilian Society of Physiology. He is also a regular speaker at national and international conferences, sharing his expertise and research findings with colleagues and students. Overall, Dr. Nunes is a highly qualified and experienced professional in physiological sciences, metabolism, cancer and nutrition. His dedication to research and education makes him a valuable asset to any institution.
Most Relevant Publications (1+)

97 total publications

1739-P: Insulin Rapidly Increases Skeletal Muscle Mitochondrial ADP Sensitivity, Mitigating HFD-Induced Mitochondrial Dysfunction

Diabetes / Jun 01, 2020

BRUNETTA, H., PETRICK, H. L., NUNES, E. A., & HOLLOWAY, G. (2020). 1739-P: Insulin Rapidly Increases Skeletal Muscle Mitochondrial ADP Sensitivity, Mitigating HFD-Induced Mitochondrial Dysfunction. Diabetes, 69(Supplement_1). https://doi.org/10.2337/db20-1739-p

See Full Profile

John M Baust, Ph.D

Ithaca, New York, United States of America
25 Years Experience
Proven success in delivering best-in-class services across scientific, commercial and education environments.
Education

Harvard Medical School

Post Doc

Boston, Massachusetts, United States of America

Binghamton University

Ph.D.

Binghamton, New York, United States of America

Cornell University

BS

Ithaca, New York, United States of America
Experience

Cell Preservation Services (United States)

President

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (16)
Cell Biology
Biotechnology
Biomedical Engineering
Transplantation
Surgery
And 11 more
About
***Proven success in delivering best-in-class services across highly regulated scientific and commercial environments.*** * Resourceful, dynamic, and future-focused professional; equipped with strategic leadership, business, research, and academic expertise with career excellence in conducting in-depth research, leading multi-faceted R&D projects, and developing new products and treatments. * Dedicated, driven self-starter focused on developing innovative life changing technologies and procedures advancing the areas of cancer treatment, regenerative medicine and cell therapy.   * Substantial experience in providing oversight for medical device development, pre-clinical studies, cancer therapy, stem cell preservation, cell therapy, tissue engineering, and organ transplantation, etc. * Astute at establishing solid relationships with stakeholders and industry leaders to drive innovative ideas and lead collaborative efforts in pursuit of accomplishing long-term milestones. * Successful in delivering interactive academic instruction across higher education settings offering captivating lectures on Biology and Entrepreneurship courses in accordance with the organizational mission. * Accredited with authoring, managing, and executing multi-million dollar grants, corporate contracts * Accomplished author of numerous patents and high profile publications to disseminate essential research findings.
Most Relevant Publications (1+)

68 total publications

Evaluation of a new epicardial cryoablation system for the treatment of Cardiac Tachyarrhythmias

Trends in Medicine / Jan 01, 2018

M. Baust, J., Robilotto, A., Snyder, K., Van Buskirk, R., & G. Baust, J. (2018). Evaluation of a new epicardial cryoablation system for the treatment of Cardiac Tachyarrhythmias. Trends in Medicine, 18(1). https://doi.org/10.15761/tim.1000125

See Full Profile

Jeffrey Townsend

New Haven, CT, Connecticut, United States of America
29 Years Experience
Professor of Biostatistics and Ecology & Evolutionary Biology
Education

Harvard University

Ph.D., Organismic and Evolutionary Biology / May, 2002

Cambridge, Massachusetts, United States of America

Brown University

Sc.B., Biology / May, 1994

Providence, Rhode Island, United States of America
Experience

Yale University

Professor / July, 2018 — Present

Elihu Professor of Biostatistics / July, 2018 — Present

Elihu Associate Professor of Biostatistics / July, 2017 — June, 2018

Associate Professor / July, 2013 — June, 2018

Associate Professor / July, 2013 — June, 2017

Assistant Professor / July, 2006 — June, 2013

University of Connecticut

Assistant Professor / August, 2004 — May, 2006

St. Ann's School

Teacher / September, 1994 — June, 1997

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (52)
Evolutionary Genomics
Microbiology
Infectious Diseases
Genetics
Cell Biology
And 47 more
About
Jeffrey Townsend is a Professor of Organismic and Evolutionary Biology at Yale University. He received his Ph.D. from Harvard University in 2002 and his Sc.B. from Brown University in 1994. He has been a teacher at St. Ann's School and an Assistant Professor at the University of Connecticut. He is currently the Elihu Professor of Biostatistics at Yale University.
Most Relevant Publications (1+)

207 total publications

Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study

The Lancet Regional Health - Europe / Mar 01, 2022

Wells, C. R., Pandey, A., Fitzpatrick, M. C., Crystal, W. S., Singer, B. H., Moghadas, S. M., Galvani, A. P., & Townsend, J. P. (2022). Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study. The Lancet Regional Health - Europe, 14, 100304. https://doi.org/10.1016/j.lanepe.2021.100304

See Full Profile

Balamurugan Tangiisuran

Boston, Massachusetts, United States of America
14 Years Experience
Associate Professor in Clinical Pharmacy at Universiti Sains Malaysia
Education

Ph.D, Medication safety in Geriatrics / March, 2010

Sussex
Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (51)
Geriatrics
Pharmacy
Psychiatry and Mental health
Clinical Psychology
Pharmacology
And 46 more
About
Dr. Bala brings a wealth of knowledge and expertise to his role as an Associate Professor in Clinical Pharmacy at the School of Pharmaceutical Sciences, USM. He has a proven track record of success in his field, having held key leadership positions such as Director at the Malaysian National Poison Centre and Program Chairman (Clinical Pharmacy) at the School of Pharmaceutical Sciences, USM. He holds a Bachelor of Pharmacy from USM and a PhD from Brighton and Sussex Medical School, UK. Additionally, he has been appointed as Visiting Senior Lecturer at King's College London and as a Fellow of the WHO Collaborating Centre for Drug Information at the National Poison Centre. <br> Bala's research focuses on the areas of clinical pharmacy practice and medication safety, as well as geriatric pharmacy. He has published more than 50 peer-reviewed journal articles/abstracts and has been invited as a guest speaker at numerous international and domestic scientific events. He is an experienced internal and external examiner for over 40 PhD and Master thesis and has actively reviewed manuscripts for international academic journals. Bala's teaching activities encompass both undergraduate and postgraduate-level instruction, and he has supervised the research of numerous postgraduate students. He is committed to curriculum development and has implemented innovative and interactive teaching methods to improve student learning outcomes. He has successfully graduated 24 students, including 4 PhDs, 4 MSc, and 16 Master in Clinical Pharmacy. He is dedicated to producing sustainable pharmacy education and closing the knowledge transfer gap for students. If you're interested in Clinical Pharmacy, Geriatric pharmacy, Medication Safety, Research and Education, feel free to connect and exchange ideas.
Most Relevant Publications (3+)

78 total publications

Development and Validation of a Score to Assess Risk of Adverse Drug Reactions Among In-Hospital Patients 65 Years or Older

Archives of Internal Medicine / Jul 12, 2010

Onder, G., Petrovic, M., Tangiisuran, B., Meinardi, M. C., Markito-Notenboom, W. P., Somers, A., Rajkumar, C., Bernabei, R., & van der Cammen, T. J. M. (2010). Development and Validation of a Score to Assess Risk of Adverse Drug Reactions Among In-Hospital Patients 65 Years or Older: The GerontoNet ADR Risk Score. Archives of Internal Medicine, 170(13). https://doi.org/10.1001/archinternmed.2010.153

Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia

Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews / Jul 01, 2019

Balasubramaniam, S., Lim, S. L., Goh, L. H., Subramaniam, S., & Tangiisuran, B. (2019). Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia. Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews, 13(4), 2585–2591. https://doi.org/10.1016/j.dsx.2019.07.011

694 THE EVALUATION OF PREVALENCE AND AWARENESS TOWARDS HYPERTENSION CONTROL AMONG HEALTHCARE EMPLOYEES IN THE KERIAN DISTRICT

Journal of Hypertension / Sep 01, 2012

Omar, W. A. W., Yusoff, Z. M., Hassali, M. A., & Tangiisuran, B. (2012). 694 THE EVALUATION OF PREVALENCE AND AWARENESS TOWARDS HYPERTENSION CONTROL AMONG HEALTHCARE EMPLOYEES IN THE KERIAN DISTRICT. Journal of Hypertension, 30(Supplement 1), e201. https://doi.org/10.1097/01.hjh.0000420669.92908.bc

See Full Profile

Steve Joordens

UofT Professor of Psychology with a passion for preventive mental health and education
Education

University of Waterloo

Ph.D., Psychology / January, 1994

Waterloo, Ontario, Canada
Experience

Advisory Board Member for OOt Social

Scientific Advisor Committee Member for The GenWell Initiative

Chief Science Officer and Cofounder of Cogneeto.inc

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (29)
Memory
Educational Technologies
Developing Transferable Skills
Developmental and Educational Psychology
Experimental and Cognitive Psychology
And 24 more
About
Initially trained as a Cognitive Psychologist with expertise on conscious versus unconscious influences on performance, Steve has more recently become a strong proponent of preventative mental health efforts. During the pandemic Steve created a free online course at Coursera.org entitled Understanding and Managing the Anxiety of COVID 19, a course that has over 180,000 registered students. That lead him to then created more specialized courses, one supporting Police Officers and another supporting Health Care Workers, providing each with a better understanding of the stressors associated with their chosen work, and giving them tips and strategies for managing their mental health. Since then Steve has become a common media commentator around preventative mental health, and has begun supporting both not for profits (The GenWell Initiative) and commercial entities (OOt Social) to bring mental health support to corporations, students, and the general public.
Most Relevant Publications (1+)

77 total publications

Is Looking Older than One’s Actual Age a Sign of Poor Health?

Journal of General Internal Medicine / Oct 28, 2010

Hwang, S. W., Atia, M., Nisenbaum, R., Pare, D. E., & Joordens, S. (2010). Is Looking Older than One’s Actual Age a Sign of Poor Health? Journal of General Internal Medicine, 26(2), 136–141. https://doi.org/10.1007/s11606-010-1537-0

See Full Profile

Mohsen Fathzadeh

Research Scientist, Genomics, Stanford University
Education

Tehran University of Medical Sciences

Medical Genetics / 2015

Tehran

Stanford University

PhD Fellowship, Genetics / 2021

Stanford, California, United States of America

Yale University

Postgraduate, Cardiovascular Genetics / 2015

New Haven, Connecticut, United States of America
Experience

Stanford U

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (16)
Genomic Medicine
Translational Genomics
Diabetes Prevention
Cardiometabolic Diseases
Single-Cell Genomics
And 11 more
About
## Scientist Genomics I have my major, MSc, and PhD degrees in biology, human, and medical genetics. I have hands-on experience in a variety of molecular biology and genetic techniques and have worked on NGS library preparation, scRNA-seq, and data analysis. As shown in my resume (I can also send my CV if needed), in addition to genomic experiments, I have worked on other omic profiling such as epigenome (DNA methylation), proteomics, and transcriptomics in a variety of samples including human cells and animal tissues. With more than 20 years of work experience, I have worked in hospital, academic, and biotech settings and proactively had to take a strategic thinking and problem-solving approach. Thus, I am adaptable to changing directions and methods, and eager to work in a dynamic, fast-paced research and product development environment. I also have multiple experiences managing multicenter and international collaborations and managing multiple priorities in a cross-functional team. I personally give fundamental value to diversity and building new connections and collaborations, and learning from diverse team members. Continuous learning and teamwork are my core values. There are other examples of my attention to detail, optimizing and troubleshooting techniques and experiments in molecular biology, genomics, and NGS panel design. As an example of my resilience, in a collaboration between CZ Biohub and the Stanford Pediatrics Department, I had to pilot a split-seq and combinatorial barcoding NGS method for newborn lung samples from library preparation up to scRNA-seq analysis. With a strong background in genomics and biology and expertise in the wet lab and data analysis, I could be a valuable asset to the Product Development teams where they need someone to lead and advance genomics research and NGS technology development, outreach, and shaping the future of genomics research, especially in clinical genetics and medical genomics. As I pursue a multidisciplinary collaboration in my scientific rationale, particularly, I am eager to extend my dedication to commercialization and envision the genomics product for financial gain and bringing value to the market. In summary, I have expertise and am eager to continue to design, conduct, and optimize new biological and genomics experiments and elucidate underlying mechanisms. I have more than 20 years of direct work experience in clinical research, both within hospital settings and in functional genomics labs. These roles required me to perform a variety of monitoring tasks depending on the context. This included monitoring lab and patient data, as well as monitoring various types of data such as clinical, molecular, and omics data, including genomics and proteomics. I have experience in developing IVD tests such as NGS panels and Polygenic Risk Scores (PRS) for genetic diseases.
Most Relevant Publications (1+)

30 total publications

1736-P: Insulin Resistance and Mitochondrial Dysfunction Mediated by Nat1 Deficiency

Diabetes / Jun 01, 2020

SANGWUNG, P., FATHZADEH, M., & KNOWLES, J. (2020). 1736-P: Insulin Resistance and Mitochondrial Dysfunction Mediated by Nat1 Deficiency. Diabetes, 69(Supplement_1). https://doi.org/10.2337/db20-1736-p

See Full Profile

Luke Connelly

25 Years Experience
Professor of Health Economics, The University of Queensland, CBEH
Education

University of Queensland

PhD, School of Economics / June, 1999

Brisbane, Queensland, Australia

University of Queensland

Master of Economic Studies, School of Economics / December, 1993

Brisbane, Queensland, Australia

University of Queensland

Bachelor of Arts (Economics), School of Economics / November, 1991

Brisbane, Queensland, Australia
Experience

The University of Bologna

Professor

The University of Queensland

Professor of Health Economics / May, 2015 — Present

Professor of Health Economics and Associate Director / January, 2008 — August, 2015

Associate Professor and Associate Director / May, 2003 — December, 2007

Queensland University of Technology

Senior Lecturer in Economics / May, 2000 — April, 2003

Lecturer / January, 1998 — April, 2000

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (42)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 37 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.
Most Relevant Publications (2+)

105 total publications

Cost of screening for lung cancer in Australia

Internal Medicine Journal / Nov 01, 2019

Marshall, H. M., Finn, N., Bowman, R. V., Passmore, L. H., McCaul, E. M., Yang, I. A., Connelly, L., & Fong, K. M. (2019). Cost of screening for lung cancer in Australia. Internal Medicine Journal, 49(11), 1392–1399. Portico. https://doi.org/10.1111/imj.14439

Post‐traumatic stress disorder is associated with a higher rate of polypectomy independent of an increased frequency of colonoscopy in Australian veterans: a retrospective review

Internal Medicine Journal / Jun 11, 2022

Crawford, D. H. G., Mellor, R., Teo, A., Duenow, P., & Connelly, L. B. (2022). Post‐traumatic stress disorder is associated with a higher rate of polypectomy independent of an increased frequency of colonoscopy in Australian veterans: a retrospective review. Internal Medicine Journal, 53(8), 1423–1428. Portico. https://doi.org/10.1111/imj.15818

See Full Profile

Monica Motley, PhD, MSEd, MPH

15 Years Experience
Social and Behavioral Health Scientist specializing in health equity, organizational change, and community disparities
Education

Virginia Tech

Doctor of Philosophy , VA/Maryland Regional College of Veterinary Medicine

Blacksburg

Virginia Tech

Master of Public Health, Population Health Science

Blacksburg

Virginia Tech

Master of Science in Education , School of Education

Blacksburg
Experience

Virginia Tech

Adjunct Teaching Faculty / 2023 — Present

The Motley Consulting Group, LLC

CEO & Founder / 2017 — Present

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (13)
Public Health
Health Equity
STEMH Workforce Development
Social Determinants of Health
Public Health, Environmental and Occupational Health
And 8 more
About
Dr. Monica Motley is a highly accomplished educator and public health professional with a diverse background in social justice, public health, and health equity. She holds a Doctor of Philosophy degree in Veterinary Medicine from the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech, as well as a Master of Public Health degree in Population Health Science and a Master of Science in Education from the same university. Dr. Motley has a strong passion for research and has served as a faculty member at Virginia Tech for the past decade, where she has taught, served on graduate committees, and managed various complex research projects. She also works as a consultant via her own boutique firm, providing expert guidance to organizations and government agencies on various equity-related topics. In addition, Dr. Motley founded *The Motley Consulting Group, LLC in 2017*, a consulting firm that specializes in community disparities and health inequities. Through her company, she has helped numerous clients develop effective strategies and programs to address equity-based organizational change, health disparity assessment, and health resources. Dr. Motley's extensive education and experience make her a highly sought-after specialist in her field. She is dedicated to making a positive impact on the health and education of individuals and communities and continues to be a leader in her field through her work and advocacy efforts.

See Full Profile

Roshonda Jones

Charlotte, North Carolina, United States of America
7 Years Experience
Bioinformatics research scientist using computational and statistical techniques to examine the relationship between diet, health and microbes
Education

University of North Carolina at Charlotte

Ph.D., Bioinformatics and Computational Biology / August, 2016

Charlotte, North Carolina, United States of America

North Carolina Agricultural and Technical State University

B.S., Applied Mathematics / May, 2011

Greensboro, North Carolina, United States of America
Experience

University of Southern California

Postdoctoral Scholar / September, 2016 — December, 2018

Childrens Hospital Los Angeles

Postdoctoral Research Fellow / January, 2019 — November, 2020

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (23)
Bioinfomatics
Microbiome
Childhood Obesity
Microbiology
Microbiology (medical)
And 18 more
About
Roshonda Jones is an experienced bioinformatics and computational biologist with a passion for exploring the complexities of life. She earned her Ph.D. in Bioinformatics and Computational Biology from University of North Carolina at Charlotte in 2016, and went on to complete a postdoctoral fellowship at USC, as well as a postdoctoral research fellowship at Children’s Hospital Los Angeles. Her research interests include machine learning and bioinformatics. She is committed to using her expertise to further scientific knowledge and advance the field.
Most Relevant Publications (1+)

43 total publications

1252-P: Effects of a Pilot Sugar-Reduction Intervention on Diet and Continuous Blood Glucose in Teenagers on the Remote Pacific Island of Kiritimati

Diabetes / Jun 01, 2020

PLOWS, J., RIOS, C., BERGER, P., JONES, R. B., ALDERETE, T. L., STEINBERG, S., BANGAO, T., BEALE, E., & GORAN, M. I. (2020). 1252-P: Effects of a Pilot Sugar-Reduction Intervention on Diet and Continuous Blood Glucose in Teenagers on the Remote Pacific Island of Kiritimati. Diabetes, 69(Supplement_1). https://doi.org/10.2337/db20-1252-p

See Full Profile

Yuri Bukhtiyarov

25 Years Experience
Expert in small molecule drug discovery and preclinical/early clinical development of drug candidates with a track record of accomplishments and publications in peer-reviewed scientific journals
Education

Drexel University Bennett S LeBow College of Business

MBA, Finance / June, 2002

Philadelphia, Pennsylvania, United States of America

Russian Academy of Sciences

PhD, Memebrane Biochemistry / May, 1997

Pushchino

Moscow State University Department of General Chemistry

MS, Radiochemistry / June, 1986

Moscow
Experience

Vitae Pharmaceuticals Inc

Senior Research Fellow / September, 2002 — December, 2016

Principal Investigator overseeing assay development, in vitro pharmacology and animal studies on multiple drug discovery projects. Directed development and implementation of cell proliferation, differentiation and apoptosis assays for oncology and immunology projects, functional assays and target engagement studies in tissues, plasma, primary human and rodent cells. • Designed and managed various studies conducted by the CROs and academic groups including efficacy studies in rodents and Cynomolgus monkeys, DNA microarray and RNA-Seq differential gene expression analysis studies, PK, tissue distribution, DDI and off-target activity assays. • Contributed to the IND filing of several clinical candidates, prepared IND-enabling documents using submission authoring templates StartingPoint (Accenture). Conducted preliminary analysis of clinical results from the Psoriasis (RORγt inverse agonist) and Atopic Dermatitis (LXR agonist) trials.

Dade Behring

Senior Research Scientist / February, 2002 — August, 2002

Method Leader on development of clinical immunochemical assays for cardiac markers on the Dimension instruments platform. • Served as R&D Project Leader on a cross-functional product development teams focused on validation of clinical assays in a GLP/ISO9001 environment. Made a major contribution to invention of new highly sensitive assays for adulteration of urine in analysis of drugs of abuse.

EI Dupont de Nemours and Co

Research Scientist / April, 1999 — October, 2001

Principal investigator in Anti-Bacterial Department working on assay development for projects targeting protein synthesis, tRNA aminoacylation, cell-wall biosynthesis and DNA replication. • Developed and validated HTS-compatible assays for inhibition of protein synthesis in bacteria based on the in vitro transcription/translation of the firefly luciferase reporter gene. • Established assays for inhibition of bacterial aminoacyl-tRNA synthetases (AARS) by monitoring aminoacylation status of individual tRNA’s in bacterial cells by Northern blot analysis.

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (22)
Drug Discovery
Cell Biology
Biochemistry
Molecular Biology
Molecular Medicine
And 17 more
About
Extensive industrial research experience focused on Drug Discovery, In Vitro Diagnostics, Biochemistry, Molecular and Cell Biology. • A record of accomplishments including five research projects taken from their inception to IND filing and advancing seven compounds into clinic. • Experience with validation of novel drug targets and evaluation of small molecule drug candidates in functional assays and animal models. Deep knowledge of assay development, including cell-based and enzyme/receptor assays. • Broad expertise in Biological Sciences - enzymology, molecular biology, bioanalytical protocols, protein expression and purification, protein chemistry, immunochemistry, cell biology and cell signal transduction. • Experience with outsourcing of DMPK, in vitro Pharmacology, DDI and efficacy studies, working with CRO and Academic groups on Target Validation and Preclinical Drug Development. • Expertise with database management, deposition of structured results and analysis of large data arrays including data mining and statistical analysis.
Most Relevant Publications (1+)

37 total publications

THE RENIN INHIBITOR VTP-27999 BLOCKS STORED RENIN MORE POTENTLY THAN ALISKIREN

Journal of Hypertension / Jun 01, 2011

Krop, M., Gregg, R., McGeehan, G., & Danser, A. (2011). THE RENIN INHIBITOR VTP-27999 BLOCKS STORED RENIN MORE POTENTLY THAN ALISKIREN: PP.25.286. Journal of Hypertension, 29, e377. https://doi.org/10.1097/00004872-201106001-01110

See Full Profile

Miguel Ramirez

38 Years Experience
Ward S. Curran Distinguished Professor of Economics, Trinity College
Education

University of Illinois Urbana-Champaign

Ph.D., Economics

Urbana, Illinois, United States of America

University of Illinois Urbana-Champaign

MS, Economics

Urbana, Illinois, United States of America
Experience

Trinity College

Ward S. Curran Distinguished Professor of Economics / 1985 — Present

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (45)
Foreign Direct Investment
Latin American Economics
Public investment
Marxian economics.
Development
And 40 more
About
Professor Ramirez is a native of Chile and a naturalized U.S. citizen since 1990. He received his Ph.D. in economics from the University of Illinois at Urbana-Champaign in 1984 and has been at Trinity College since 1985. He has held visiting positions at the University of Illinois at Champaign-Urbana (Summer 1991 and 1992), Haverford College (Spring 1992), Vanderbilt University (Spring 1999), and Yale University (Spring 2006). His teaching interests are primarily in the areas of Latin American economic development and international finance and open economy macroeconomics. At the College he usually offers Latin American economic development and Structural Reform in Latin America during the fall term, while international finance and open economy macroeconomics is taught during the spring term. He also teaches a course in Time-Series Analysis every other spring term, with particular emphasis on unit root and cointegration analysis, error correction modeling, and forecasting. Insofar as his research is concerned, it is primarily dedicated to analyzing the challenges and opportunities that Latin American nations face as they attempt to stabilize and reform their economies in an increasingly globalized world. In particular, his work has reviewed and analyzed the impact of IMF-sponsored adjustment and stabilization measures in Argentina, Chile, and Mexico, as well as the mixed success of structural reform programs such as privatization of state-owned firms, deregulation of economic activity, and liberalization of trade and finance. His research has also focused on the economic and institutional determinants of foreign direct investment in Argentina, Chile, and Mexico, as well as the impact of these flows on private capital formation and labor productivity growth in Latin America. Another important focus of his work in recent years has been the growing role of remittance flows in financing private investment spending and boosting economic growth in countries such as Ecuador, the Dominican Republic, El Salvador, Jamaica, and Mexico. Finally, he has published work in the history of economic thought relating to Marx's important analysis of wages and cyclical crises, his theory of absolute and differential ground rent, his analysis of the falling rate of profit, Marx's controversial writings on the so-called Asiatic mode of production, and his conception of capital as a social process.
Most Relevant Publications (1+)

89 total publications

Do Remittances Promote Labor Productivity in Mexico? A DOLS and FMOLS Analysis, 1970-2017

Bulletin of Applied Economics / Feb 16, 2023

Ramirez, M. D. (2023). Do Remittances Promote Labor Productivity in Mexico? A DOLS and FMOLS Analysis, 1970-2017. Bulletin of Applied Economics, 115–131. https://doi.org/10.47260/bae/1016

See Full Profile

Marina Baretti

Baltimore, Maryland, United States of America
2 Years Experience
I am a clinical translational researcher in gastrointestinal (GI) oncology, collaborating closely with laboratory-based researchers to move laboratory findings into patients and to answer important clinical questions.
Experience

Johns Hopkins University

Co-Director of the Liver and Biliary Cancer Multidisciplinary Clinic at Johns Hopkins, Baltimore, MD / January, 2023 — Present

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins School of Medicine, Baltimore, MD

Assistant professor / October, 2021 — Present

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (14)
Oncology
Pharmacology (medical)
Pharmacology
Hematology
Gastroenterology
And 9 more
About
Throughout my training, I have been focused toward my ultimate goal of becoming a clinical translational researcher in gastrointestinal (GI) oncology, collaborating closely with laboratory-based researchers to move laboratory findings into patients and to answer important clinical questions. My clinical research is centered on the development of novel agents in GI cancers, with particular interest in combinatorial approaches of epigenetic therapies and immunotherapies combinations. I ran the first phase II study of combination epigenetic therapy and immunotherapy in advanced pancreatic adenocarcinoma and cholangiocarcinoma, working with a collaborative team that incorporates leading experts in cancer immunology, epigenetics and drug development. I was awarded the 2018 ASCO Conquer Cancer Foundation Young Investigator Award for this project.  Together with Dr. Yarchoan, we are running a clinical trial of a novel neoantigen-specific vaccine in combination with immune checkpoint inhibitors for advanced fibrolamellar carcinoma (FLC) (NCT04248569). My laboratory focus has been on developing and validating a preclinical mouse model of FLC to investigate mechanisms underlying FLC pathogenesis, and will become a critical tool for investigating novel therapeutic strategies in FLC.
Most Relevant Publications (3+)

54 total publications

Targeting the epigenome of pancreatic cancer for therapy: challenges and opportunities

Annals of Pancreatic Cancer / Oct 01, 2019

Baretti, M., Ahuja, N., & Azad, N. S. (2019). Targeting the epigenome of pancreatic cancer for therapy: challenges and opportunities. Annals of Pancreatic Cancer, 2, 18–18. https://doi.org/10.21037/apc.2019.10.01

Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors

Pancreas / May 01, 2021

Baretti, M., Zhu, Q., Zahurak, M., Bhaijee, F., Xu, H., Engle, E. L., Kotte, A., Pawlik, T. M., Anders, R. A., & De Jesus-Acosta, A. (2021). Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors. Pancreas, 50(5), 719–726. https://doi.org/10.1097/mpa.0000000000001831

The Significance of Ascites in Patients With Pancreatic Ductal Adenocarcinoma

Pancreas / Apr 01, 2019

Baretti, M., Pulluri, B., Tsai, H.-L., Blackford, A. L., Wolfgang, C. L., Laheru, D., Zheng, L., Herman, J., Le, D. T., Narang, A. K., & de Jesus-Acosta, A. (2019). The Significance of Ascites in Patients With Pancreatic Ductal Adenocarcinoma. Pancreas, 48(4), 585–589. https://doi.org/10.1097/mpa.0000000000001262

See Full Profile

Maria Daniela Defagó

18 Years Experience
Professor and researcher, Universidad Nacional de Córdoba and CONICET
Education

Universidad de Buenos Aires

MSc in Clinical Effectiveness

Buenos Aires

Universidad Nacional de Córdoba

PhD in Health Sciences / August, 2010

Cordoba

Universidad Nacional de Córdoba

Bs in Nutrition / May, 2003

Cordoba
Experience

Instituto de Investigaciones en Ciencias de la Salud (INICSA), CONICET

October, 2016 — Present

Universidad Nacional de Córdoba, Facultad de Ciencias Médicas, Escuela de Nutrición

Professor, researcher / August, 2006 — Present

Most Relevant Research Expertise
Internal Medicine
Other Research Expertise (36)
nutrición
epidemiología
evaluación nutricional
genómica nutricional
Nutrition and Dietetics
And 31 more
About
María Daniela Defagó graduated with a Bachelor's Degree in Nutrition (2003), later obtaining the title of Technical Assistant in Bromatology (2004), a Doctor of Health Sciences at the National University of Córdoba (2010) and a Master's Degree in Clinical Effectiveness from the University of Buenos Aires (2017). She completed her postdoctoral degree in the Department of Cardiovascular Epidemiology at Tulane University (New Orleans, United States, 2011-2012), training in genetic and molecular epidemiology. She was a fellow of the Bernard Lown Cardiovascular Health program at Harvard University, United States (2014). She currently works as a teacher-researcher at the School of Nutrition of the Faculty of Medical Sciences (UNC), an associate researcher at INICSA-CONICET and as an associate researcher at the Center of Excellence in Cardiovascular Health (Institute of Clinical and Health Effectiveness, Buenos Aires). Aires). Her line of research includes the study of chronic diseases and biomarkers. She has participated in numerous national and international scientific events and has publications in international scientific journals. She is co-director of the Public Health Magazine of the National University of Córdoba since 2021.
Most Relevant Publications (2+)

63 total publications

Influence of Food Patterns on Endothelial Biomarkers: A Systematic Review

The Journal of Clinical Hypertension / Nov 06, 2014

Defagó, M. D., Elorriaga, N., Irazola, V. E., & Rubinstein, A. L. (2014). Influence of Food Patterns on Endothelial Biomarkers: A Systematic Review. The Journal of Clinical Hypertension, 16(12), 907–913. Portico. https://doi.org/10.1111/jch.12431

Common Genetic Variants in the Endothelial System Predict Blood Pressure Response to Sodium Intake: The GenSalt Study

American Journal of Hypertension / Feb 26, 2013

Defago, M. D., Gu, D., Hixson, J. E., Shimmin, L. C., Rice, T. K., Gu, C. C., Jaquish, C. E., Liu, D.-P., He, J., & Kelly, T. N. (2013). Common Genetic Variants in the Endothelial System Predict Blood Pressure Response to Sodium Intake: The GenSalt Study. American Journal of Hypertension, 26(5), 643–656. https://doi.org/10.1093/ajh/hps099

See Full Profile

Example Internal Medicine projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Internal Medicine?

Drug Development and Testing

An academic researcher in Internal Medicine can collaborate with pharmaceutical companies to develop and test new drugs. Their expertise in disease mechanisms, pharmacology, and clinical trials can help companies identify potential drug targets, design effective treatment strategies, and ensure the safety and efficacy of new medications.

Medical Device Innovation

Companies specializing in medical devices can benefit from collaborating with Internal Medicine researchers. These experts can provide insights into the clinical needs and challenges faced by healthcare professionals, helping companies develop innovative and user-friendly medical devices. Academic researchers can also contribute to the evaluation and validation of medical devices through clinical trials and usability studies.

Healthcare Data Analysis

With the increasing availability of healthcare data, companies can collaborate with Internal Medicine researchers to analyze and interpret large datasets. These experts can apply their knowledge of statistical analysis and epidemiology to uncover patterns, trends, and insights from healthcare data. This collaboration can help companies make data-driven decisions, improve patient outcomes, and optimize healthcare delivery.

Clinical Research and Trials

Internal Medicine researchers can play a crucial role in conducting clinical research and trials for pharmaceutical companies and healthcare organizations. Their expertise in study design, patient recruitment, data collection, and analysis can ensure the success and validity of clinical trials. Collaborating with academic researchers can accelerate the development of new treatments and therapies.

Medical Education and Training

Companies in the healthcare industry can collaborate with Internal Medicine experts to develop educational materials and training programs. These experts can contribute their knowledge and experience to create engaging and informative content for healthcare professionals, students, and patients. By collaborating with academic researchers, companies can enhance the quality of medical education and training materials.